文献速递临床试验与 GCP基础与转化研究

Roux-en-Y胃旁路术与单吻合口胃旁路术的前瞻性随机对照试验:RYSA试验方案与中期分析

Prospective randomized controlled trial comparing the efficacy and safety of Roux-en-Y gastric bypass and one-anastomosis gastric bypass (the RYSA trial): trial protocol and interim analysis.
PubMed 文献 · Trials · 2019-12-30

RYSA试验是一项在两家学术中心开展的前瞻性随机对照研究,计划纳入120例减重手术患者,随机分配至RYGB或OAGB组,随访10年,比较两种术式的疗效与安全性,并进行广泛代谢研究。中期分析(每组30例)显示无死亡和ICU入住,结论为试验可安全进行。

要点

  • RYGB与OAGB的前瞻性随机对照证据缺乏,RYSA试验旨在填补此空白。
  • 中期分析每组30例,无死亡及ICU入住,试验可安全继续。
  • 所有患者随访10年,赫尔辛基大学医院患者(80例)额外进行代谢和胆汁反流研究。

核心结论

  • 中期分析表明RYGB与OAGB对比试验可安全开展,招募预计2019年底完成。

研究设计与样本

  • 前瞻性随机对照试验,计划纳入120例减重手术患者,在两家学术中心随机分配至RYGB或OAGB组。
  • 所有患者随访10年,分析体重、合并症、血液检查、体成分和问卷。
  • 赫尔辛基大学医院治疗的80例患者额外在基线、6个月和12个月进行广泛代谢分析(混合餐试验、能量消耗、肌肉和皮下脂肪活检、尿液、唾液和粪便样本)。
  • OAGB组在赫尔辛基大学医院6个月时通过胃镜和闪烁扫描研究胆汁反流。

主要发现

  • 中期分析在招募过半时进行(30例RYGB和30例OAGB患者),无死亡和ICU入住。
  • 两组各有一例患者需要额外胃镜,RYGB组为吻合口扩张,OAGB组无额外干预。

临床怎么用

  • 中期结果支持继续开展RYGB与OAGB的随机对照试验以比较疗效与安全性。

局限性

  • 中期分析样本量小(每组30例),仅报告安全性事件,未报告疗效结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is a lack of prospective studies comparing Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB). Also, the effects of bariatric surgery and weight loss need a deeper understanding through metabolic studies. We describe the trial protocol and interim analysis of a prospective randomized controlled study comparing RYGB and OAGB: the RYSA trial. MATERIALS AND METHODS: In total, 120 bariatric patients will be randomized between RYGB and OAGB in two academic centers. All patients will be followed up for 10 years with analysis and measurements of weight, comorbidities, blood tests, body composition and questionnaires. Extensive metabolic analyses (mixed meal tests, energy expenditure, biopsies of muscle and subcutaneous fat, urine, saliva and fecal samples) will be carried out in the Obesity Research Unit, University of Helsinki, for all patients treated at the Helsinki University Hospital (80 patients) at baseline, 6 months and 12 months. Bile reflux will be studied for the OAGB group at the Helsinki University Hospital at 6 months with gastroscopy and scintigraphy. RESULTS: At an interim analysis at 3 months (half-way) through recruitment (30 RYGB and 30 OAGB patients) there have been no deaths and no intensive care unit admittances. One patient in both groups required additional gastroscopy, with anastomosis dilatation in the RYGB group but with no additional intervention in the OAGB group. CONCLUSION: The trial can be safely carried out. Recruitment is estimated to be complete by the end of 2019. TRIAL REGISTRATION: Clinical Trials Identifier NCT02882685. Registered on August 30th 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Saarinen T, Meriläinen S, Koivukangas V, et al. Prospective randomized controlled trial comparing the efficacy and safety of Roux-en-Y gastric bypass and one-anastomosis gastric bypass (the RYSA trial): trial protocol and interim analysis. Trials. 2019. PMID: 31888729. doi:10.1186/s13063-019-3898-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。